Molecular Data Inc. (MKDTY)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 28, 2025
Molecular Data Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Jun '21 Jun 30, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
| Revenue | 4,619 | 7,596 | 13,207 | 9,053 | 4,202 | 3,206 |
| Revenue Growth (YoY) | -63.12% | -42.48% | 45.88% | 115.46% | 31.06% | - |
| Cost of Revenue | 4,622 | 7,607 | 13,107 | 8,973 | 4,152 | 3,180 |
| Gross Profit | -2.68 | -10.2 | 100.77 | 80.17 | 50.23 | 26.12 |
| Selling, General & Admin | 234.45 | 277.42 | 213.33 | 277.17 | 106.68 | 100.96 |
| Research & Development | 19.06 | 35.22 | 45.04 | 36.89 | 18.61 | 20.07 |
| Operating Expenses | 262.23 | 321.36 | 292.99 | 315.96 | 139.97 | 131.89 |
| Operating Income | -264.91 | -331.56 | -192.21 | -235.79 | -89.73 | -105.77 |
| Interest Expense | -6.11 | -10.73 | -4.37 | -19.05 | -16.83 | -8.44 |
| Earnings From Equity Investments | -0.62 | -0.65 | - | - | - | - |
| Currency Exchange Gain (Loss) | 9.01 | 5.46 | 0.19 | -3.03 | -0.55 | -1.06 |
| Other Non Operating Income (Expenses) | 8.5 | 11.89 | 3.31 | 3.24 | 0.75 | 1.33 |
| EBT Excluding Unusual Items | -254.13 | -325.58 | -193.08 | -254.64 | -106.36 | -113.94 |
| Gain (Loss) on Sale of Investments | - | - | - | - | -1.45 | - |
| Pretax Income | -254.13 | -325.58 | -193.08 | -254.64 | -107.81 | -113.94 |
| Income Tax Expense | 1.49 | 2.46 | 0.47 | - | - | - |
| Earnings From Continuing Operations | -255.62 | -328.04 | -193.55 | -254.64 | -107.81 | -113.94 |
| Minority Interest in Earnings | -0.21 | 0.04 | - | - | - | - |
| Net Income | -255.83 | -328 | -193.55 | -254.64 | -107.81 | -113.94 |
| Net Income to Common | -255.83 | -328 | -193.55 | -254.64 | -107.81 | -113.94 |
| Shares Outstanding (Basic) | 10 | 8 | 7 | 7 | 7 | 7 |
| Shares Outstanding (Diluted) | 10 | 8 | 7 | 7 | 7 | 7 |
| Shares Change (YoY) | - | 12.08% | - | - | - | - |
| EPS (Basic) | -25.83 | -42.39 | -28.04 | -36.89 | -15.62 | -16.51 |
| EPS (Diluted) | -25.83 | -42.39 | -28.04 | -36.90 | -15.62 | -16.51 |
| Free Cash Flow | - | -234.05 | -96.67 | -135.12 | -187.24 | -148.16 |
| Free Cash Flow Per Share | - | -30.25 | -14.00 | -19.57 | -27.13 | -21.46 |
| Gross Margin | -0.06% | -0.13% | 0.76% | 0.89% | 1.20% | 0.81% |
| Operating Margin | -5.73% | -4.36% | -1.46% | -2.60% | -2.14% | -3.30% |
| Profit Margin | -5.54% | -4.32% | -1.47% | -2.81% | -2.57% | -3.55% |
| Free Cash Flow Margin | - | -3.08% | -0.73% | -1.49% | -4.46% | -4.62% |
| EBITDA | -259.16 | -330.97 | -190.7 | -234.42 | -88.27 | -104.81 |
| EBITDA Margin | -5.61% | -4.36% | -1.44% | -2.59% | -2.10% | -3.27% |
| D&A For EBITDA | 5.74 | 0.58 | 1.51 | 1.37 | 1.46 | 0.96 |
| EBIT | -264.91 | -331.56 | -192.21 | -235.79 | -89.73 | -105.77 |
| EBIT Margin | -5.73% | -4.36% | -1.46% | -2.60% | -2.14% | -3.30% |
| Advertising Expenses | - | 0.96 | 10.69 | 25.32 | 2.95 | 2.78 |
Source: S&P Capital IQ. Standard template. Financial Sources.